<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Digibind; Digoxin-specific antibody fragments" /><meta name="IX" content="Digibind; Digoxin-specific antibody fragments" /><title>Digibind®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="2316.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="2316.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=2316.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1002.htm">2 Cardiovascular system</a> &gt; <a href="1003.htm">2.1 Positive inotropic drugs</a> &gt; <a href="2308.htm">2.1.1 Cardiac glycosides</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="2315.htm" title="Previous: Digoxin-specific antibody">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="2317.htm" title="Next: 2.1.2 Phosphodiesterase type-3 inhibitors">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a312006.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Centruroides (Scorpion) Immune F(ab′)2 (Equine)</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Serums, Toxoids, and Vaccines 80:00 &gt; Serums 80:04</p></div></li></ul><ul><li><h3>British National Formulary (3)</h3></li><li><a href="2308.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.1.1 Cardiac glycosides</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.1 Positive inotropic drugs</p></div></li><li><a href="2315.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Digoxin-specific antibody</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.1 Positive inotropic drugs &gt; 2.1.1 Cardiac glycosides</p></div></li><li><a href="37574.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Digoxin-specific antibody fragments</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Appendix 4 Intravenous additives &gt; Use of table &gt; Table of drugs given by intravenous infusion</p></div></li></ul><ul><li><h3>BNF for Children (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2308.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">2.1.1 Cardiac glycosides</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.1 Positive inotropic drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2315.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Digoxin-specific antibody</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.1 Positive inotropic drugs &gt; 2.1.1 Cardiac glycosides</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/2316.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Digibind®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 2 Cardiovascular system &gt; 2.1 Positive inotropic drugs &gt; 2.1.1 Cardiac glycosides &gt; Digoxin-specific antibody</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/d17-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Digoxin-specific antibody fragments (Digibind, F(ab))</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; D</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/19076-q.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Digoxin-specific Antibody Fragments</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Chelators Antidotes and Antagonists &gt; Drug Monographs</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_2315">Digoxin-specific antibody</h1><div id="pC" class="jN"><div><p><b>Digoxin-specific antibody fragments</b> are indicated for the treatment of known or strongly suspected <span>digoxin</span> or other cardiac glycoside overdosage when measures
beyond the withdrawal of the cardiac glycoside and correction of any
electrolyte abnormalities are felt to be necessary (see also <a title="sub-section: Cardiac glycosides" href="2308.htm#_2308">notes above</a>).</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_2316" style="margin: 0 0 0 20px;"><h1 class="title">Digibind® <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Injection</span>, powder for preparation
of infusion, <span>digoxin</span>-specific antibody fragments
(F(ab))<div class="cAQ"><p>Available from <a title="appendix: Special-order Manufacturers" href="106216.htm#_106216">‘special-order’ manufacturers or specialist importing
companies</a></p></div></div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="2309.htm">Previous: DIGOXIN</a> | <a class="top" href="2316.htm#">Top</a> | <a accesskey="]" href="2317.htm">Next: 2.1.2 Phosphodiesterase type-3 inhibitors</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>